Antoxis ^Companies

Antoxis is a pre-clinical drug discovery company that specializes in developing treatments for various neurological conditions. They utilize their patented Kromex™ chemistry scaffold to generate New Chemical Entities (NCE) that target oxidative stress associated diseases and conditions involving mitochondrial dysfunction. Antoxis has a library of over 100 million compounds with potential to modulate these diseases. They have patent grants in key territories, and their lead compounds include oxidative stress inhibitors for regenerative medicine therapies and mitochondrial redox modulators for the treatment of drug-resistant cancer. Antoxis aims to provide innovative solutions for improving clinical outcomes and reversing treatment resistance.